<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Polymorphisms in the matrix metalloproteinase (MMP) gene have been hypothesized to be functional and may contribute to genetic susceptibility to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The common sequence variation in MMP-9 -1562 C&gt;T (rs3918242), has been involved in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
<SENT sid="2" pm="."><plain>However, results of the related published studies were somewhat controversial and underpowered in general </plain></SENT>
<SENT sid="3" pm="."><plain>To clarify the role of MMP-9 -1562 C&gt;T genotype in global <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, we performed a meta-analysis of <z:hpo ids='HP_0000001'>all</z:hpo> the available published studies involving 4,124 cancer patients and 4,728 control subjects </plain></SENT>
<SENT sid="4" pm="."><plain>The overall results indicated that there was no major association of the variant on <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk </plain></SENT>
<SENT sid="5" pm="."><plain>However, stratified analysis by <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> type showed that the MMP-9 -1562 C&gt;T polymorphism has a lower risk in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (OR = 0.80, 95%CI = 0.66-0.96, P (<z:hpo ids='HP_0001425'>heterogeneity</z:hpo>) = 0.391) and <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> (OR = 0.70, 95%CI = 0.51-0.96, P (<z:hpo ids='HP_0001425'>heterogeneity</z:hpo>) = 0.959) by allelic contrast </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, association of the MMP-9 -1562 C&gt;T polymorphism and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> risk was also observed in hospital-based studies under the dominant genetic model (OR = 0.87, 95%CI = 0.78-0.97, P (<z:hpo ids='HP_0001425'>heterogeneity</z:hpo>) = 0.355), allelic contrast (OR = 0.85, 95%CI = 0.75-0.96, P (<z:hpo ids='HP_0001425'>heterogeneity</z:hpo>) = 0.271) and heterozygote comparison (OR = 0.89, 95%CI = 0.79-0.99, P (<z:hpo ids='HP_0001425'>heterogeneity</z:hpo>) = 0.402) </plain></SENT>
<SENT sid="7" pm="."><plain>This pooled analysis showed evidence that the MMP-9 -1562 C&gt;T polymorphism may decrease both the colorectal and <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> risk </plain></SENT>
<SENT sid="8" pm="."><plain>Further prospective studies with larger numbers of participants worldwide are required to evaluate the association in more detail </plain></SENT>
</text></document>